alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

110TH CONGRESS 

2D SESSION H. R. 5049 

To suspend temporarily the duty on 5-Ethyl-2-methylpyridine. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 17, 2008 

Mr. GARRETT of New Jersey introduced the following bill; which was referred 

to the Committee on Ways and Means 

A BILL 

To suspend temporarily the duty on 5-Ethyl-2- 

methylpyridine. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 5-ETHYL-2-METHYLPYRIDINE. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 5-Ethyl-2-methylpyridine 

(CAS No. 104–90–5) (provided for in subheading 

2933.39.20) ......................... Free No change No change On or before 

12/31/2011 ’’. 


rwilkins on PROD1PC63 with BILLS
2 

HR 5049 IH 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to articles entered, or withdrawn 

3 from warehouse for consumption, on or after the 15th day 

4 after the date of the enactment of this Act. 

Æ 


rwilkins on PROD1PC63 with BILLS
Enrique Corona GOMEZ v. STATE of North Carolina.

No. 616P04.

Supreme Court of North Carolina.

February 3, 2005.

Enrique Corona Gomez, Pro Se.

William P. Hart, Special Deputy Attorney General, Thomas H. Lock, District Attorney, for State of NC.

***ORDER***

Upon consideration of the petition filed on the 2nd day of December 2004 by Plaintiff in this matter for discretionary review of the decision of the North Carolina Court of Appeals pursuant to G.S. 7A-31, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

> "Dismissed by order of the Court in conference, this the 3rd day of February 2005."
HomeOcean Facts

# Is change important to estuaries? 

## Changing conditions are a **necessary part of healthy, functioning** estuaries

Estuaries experience change many times a day due to tides. Shown here: Located at the northern end of the Ten Thousand Islands on the gulf coast of Florida, the Rookery Bay National Estuarine Research Reserve represents one of the few remaining undisturbed mangrove estuaries in North America.

Estuaries are tidally driven. Tides flush the system and  provide nutrients to keep food webs functional. By doing this, tides create constantly changing conditions of exposure to air or increased levels of water in an estuarine environment. Because of tides, the water levels in an estuary are going up and down several times a day. 

 Estuarine organisms can adapt quite well to these changing conditions in estuaries. For example, fish or crabs are mobile and can move as needed throughout the day to adjust to changes in the estuary.

 In addition, weather patterns, seasonal cycles, and climate change also affect and can change conditions in estuaries. 

 Estuaries and their surrounding wetlands are bodies of water usually found where rivers meet the sea. Estuaries are home to unique plant and animal communities that have adapted to brackish water.

###### Get **Social**

###### More **Information**

          -  National Estuarine Research Reserve System
          - Estuaries, NOS Education

**Last updated:**   01/18/24**Author:** NOAAHow to cite this article

Contact Us

            - Provide Feedback 
            -  Contact Us 
            -  Report an error 

##### Science. Service.Stewardship.

###### 						About NOS 					

            - About Us
            - NOS Program Offices
            - Media Inquiries
            - Website Acknowledgements

###### 						Resources 					

            - Site Index
            - Disclaimer
            - Freedom of Information Act
            - Accessibility

###### 						More Resources 					

            - Information Quality
            - Privacy Policy
            - NOS For Employees
            - USA.gov

          -  National Ocean Service
          -  National Oceanic and Atmospheric Administration
          -  Department of Commerce

##### 						Social 					

            - 
            - 
            - 
            - 
            -
<PAGE>



                                  EXHIBIT 32.2

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Foster Wheeler LLC (the
"Company") on Form 10-Q for the period ended March 26, 2004, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I Brian K.
Ferraioli, Vice President and Controller of the Company, certify pursuant to 18
U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

         1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of the operations of the
Company.

Date: May 14, 2004

                                                   /s/ BRIAN K. FERRAIOLI
                                                   ----------------------
                                                   Brian K. Ferraioli
                                                   Vice President and Controller
# Official Journal C 312/26 A

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 312 |
| | |
| English edition | Information and Notices | Volume 5926 August 2016 |

ISSN 1977-091X

Official Journal

of the European Union

C 312

English edition

Information and Notices

Volume 5926 August 2016

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2016/C 312/01 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2016 to 31 July 2016(Published pursuant to Article 13 or 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) | 1 |
| 2016/C 312/02 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2016 to 31 July 2016(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) | 10 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2016/C 312/01

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2016 to 31 July 2016(Published pursuant to Article 13 or 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

(Published pursuant to Article 13 or 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

1

2016/C 312/02

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2016 to 31 July 2016(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

10

---

| | Corrigenda |
| --- | --- |
| 2016/C 312/03 | Corrigendum to Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2016 to 31 March 2016
  ( OJ C 154, 29.4.2016 ) | 22 |

Corrigenda

2016/C 312/03

Corrigendum to Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2016 to 31 March 2016
  ( OJ C 154, 29.4.2016 )

( OJ C 154, 29.4.2016 )

22

---

| EN | |
| --- | --- |

EN
Exhibit








Exhibit 10.7
RPT Realty
31500 Northwestern Highway
Suite 300
Farmington Hills, MI 48334
248.350.9900
rptrealty.com




July 9, 2019




The following are provisions of Ray Merk's employment with Ramco Properties/RPT Realty effective August 6, 2018.


Position Title:        Senior Vice President, Chief Accounting Officer


Annual Base Salary:    $250,000


Annual Bonus:        Target is 40% of base salary - Target increase effective for 2018 bonus (payable in March 2019)
Based on the Company achieving its maximum performance targets and/or the Executive exceeding individual job performance targets.


Long Term Incentive:    LTIP annual grant valued at $187,500 (Target is 75% of base salary)
Target increase effective for 2019 LTIP award
Current mix of equity is 50% performance share units and 50% time-vested restricted stock units.
Equity mix and vesting is subject to change and will be determined by Compensation Committee.


Other:            Current monthly housing reimbursement of $2,000. Grossed up for tax purposes.
Annual increases commensurate with annual rent increases.


Termination without Cause*:
Cash severance equal to 1 times the sum of base salary plus a prorated annual bonus based on actual performance in the year of termination to be paid in a lump sum.


Lump sum reimbursement for COBRA/medical expense for 1 year of coverage


Equity grants are consistent with RAMCO's existing practices and terms provided to specified senior executives


Payment of severance benefit subject to execution of full release agreement in standard Trust form.


		
	Change of Control*:
	Per the terms of the Trust's current approved Change of Control Policy eligible to Senior Vice Presidents - See the attached Exhibit 10.1




*Included in both scenarios is the provision to reimburse Ray Merk any remaining term on the apartment lease as of the date of separation.




I accept the offer as outlined above.


Name:        /s/ RAYMOND MERK
Raymond Merk
July 9, 2019
**EXHIBIT31.1**

** **

**CERTIFICATIONS**

 

I, JosephRam, Chief Executive Officer and President of InfoSonics Corporation, certifythat:

 

1.             Ihave reviewed this Quarterly Report on Form 10-Q of InfoSonicsCorporation;

 

2.             Based on my knowledge, thisreport does not contain any untrue statement of a material fact or omit tostate a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading withrespect to the period covered by this report;

 

3.             Based on my knowledge, thefinancial statements, and other financial information included in this report,fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presentedin this report;

 

4.             The registrant’s othercertifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

 

(a) Designed such disclosurecontrols and procedures, or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisreport is being prepared;

 

(b) Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

 

(c) Disclosed in this reportany change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and

 

5.             The registrant’s othercertifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (or personsperforming the equivalent functions):

 

(a) All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

 

(b) Any fraud, whether or notmaterial, that involves management or other employees who have a significantrole in the registrant’s internal control over financial reporting.

 

 
| Date: May 15, 2008 |   | /s/ Joseph  Ram                                |
|-------------------------|--------|-----------------------------------------------------|
|                    |   | Joseph  Ram, Chief Executive Officer  and President |

 

----
# LI2016259EN.01000301.xml

| 27.9.2016 | EN | Official Journal of the European Union | LI 259/3 |
| --- | --- | --- | --- |

27.9.2016

EN

Official Journal of the European Union

LI 259/3

---

COUNCIL DECISION (CFSP) 2016/1711

of 27 September 2016

amending Common Position 2001/931/CFSP on the application of specific measures to combat terrorism

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union, and in particular Article 29 thereof,

Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,

Whereas:

| (1) | On 27 December 2001, the Council adopted Common Position 2001/931/CFSP (1) applying certain restrictive measures to persons, groups and entities listed in the Annex. |
| --- | --- |

(1)

On 27 December 2001, the Council adopted Common Position 2001/931/CFSP (1) applying certain restrictive measures to persons, groups and entities listed in the Annex.

| (2) | In view of the Colombia peace agreement the measures against one entity should be suspended, subject to a specific review by the Council after six months. |
| --- | --- |

(2)

In view of the Colombia peace agreement the measures against one entity should be suspended, subject to a specific review by the Council after six months.

| (3) | Common Position 2001/931/CFSP should therefore be amended accordingly, |
| --- | --- |

(3)

Common Position 2001/931/CFSP should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Common Position 2001/931/CFSP is amended as follows:

In Article 5, the following paragraph is added:

‘The measures referred to in Articles 2, 3 and 4, in so far as they apply to “Fuerzas armadas revolucionarias de Colombia” — “FARC” (“Revolutionary Armed Forces of Colombia”), shall be suspended.’.

Article 2

This Decision shall enter into force on the day of its publication in the Official Journal of the European Union.

Done at Brussels, 27 September 2016.

For the Council

The President

F. MOGHERINI

---

(1)  Council Common Position 2001/931/CFSP of 27 December 2001 on the application of specific measures to combat terrorism (OJ L 344, 28.12.2001, p. 93).

1

---
No. 99-30521 -1-

* Pursuant to 5 TH C IR . R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 99-30521 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus OSCAR RAMIREZ-GONZALES, also known as Edwin Perez, also known as Oscar Moreno-Bariento, also known as Oscar De La Cruz, Defendant-Appellant.

-------------------- Appeal from the United States District Court for the Eastern District of Louisiana

USDC No. 99-CR-8-1-A

-------------------- February 16, 2000 Before EMILIO M. GARZA, BENAVIDES, and DENNIS, Circuit Judges. PER CURIAM: * The Assistant Federal Public Defender (AFPD) appointed to represent Oscar Ramirez-Gonzales has filed a motion to withdraw from representation of Ramirez and a brief as required by Anders v. California , 386 U.S. 738 (1967). Ramirez has not responded to counsel’s motion. Our independent review of the brief and the record discloses no nonfrivolous issue. Accordingly, the APPD’s motion to withdraw is GRANTED; the AFPD is excused from furtherNo. 99-30521 -2- responsibilities herein and the APPEAL IS DISMISSED. See 5 TH C IR . R. 42.2.
EXHIBIT32.1

CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION1350, AS ADOPTED PURSUANT TO SECTION 906 OF THESARBANES-OXLEY ACT OF 2002

In connection with the QuarterlyReport on Form 10-Q of NorthStar Realty Finance Corp. (the"Company") for the quarterly period endedJune 30, 2005, as filed with the Securities and Exchange Commission onthe date hereof (the "Report"), David T.Hamamoto, as Chief Executive Officer of the Company, hereby certifies,pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that, to the best of hisknowledge:

(1) The Report fully complies with therequirements of Section 13(a) or 15(d) of the Securities Exchange Actof 1934; and

(2) The information contained in the Reportfairly presents, in all material respects, the financial condition andresults of operations of the Company.

|                                           |                                                                                                        |
|-------------------------------------------|--------------------------------------------------------------------------------------------------------|
| Date: August 12,2005  By:  | /s/   David T.Hamamoto Name: David T. Hamamoto Title:  ChiefExecutive Officer |

This certification accompaniesthe Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002and shall not, except to the extent required by the Sarbanes-Oxley Actof 2002, be deemed filed by the Company for purposes of Section 18 ofthe Securities Exchange Act of 1934, as amended.

A signedoriginal of this written statement required by Section 906 of theSarbanes-Oxley Act of 2002 has been provided to the Company and will beretained by the Company and furnished to the Securities and ExchangeCommission or its staff uponrequest.

----
DEMAND


PROMISSORY NOTE


 


	$
    500,000.00	Dated
    as of July 18, 2019


 


For
Value Received, H-Cyte, Inc., hereinafter called “Debtor,” promises to pay to Horne Management, LLC,
located at 612 SE 5th Avenue, Suite 6, Florida, 33301, hereinafter called “Creditor,” the principal
sum of FIVE HUNDRED THOUSAND DOLLARS ($500,000.00) with interest from the date hereof on the unpaid principal balance at the
rate of 5.5% per annum.


 


I. Repayment
Schedule -The Note is due and payable on demand of the Creditor.


 


2. Manner
and Place of Payment - Each payment shall be made in lawful money of the United States of America and payable in
immediately available funds at Creditor’s current address as set forth above or at such other place as the legal holder
hereof shall from time to time designate to Debtor in writing. If any payment of principal or interest on this Note is due on
a Saturday, a Sunday, or a legal holiday under the laws of the State of Florida, such payment shall be made on the next
succeeding business day, and such extension of time shall be included in computing interest in connection with such
payment.


 


3. No
Oral Agreements - This Note is the final expression of the agreement between the parties. This document may not be
contradicted by evidence of prior or contemporaneous oral agreements of the parties. There are no unwritten oral agreements
between the parties.


 


4 Miscellaneous -
This Note shall be binding upon Debtor and its successors and assigns, and shall insure to the benefit of Creditor and its
successors, transferees and assigns, and all parties who may become holders of this Note. This Note is made and executed
under and shall in all respects be governed and enforced by, and construed in accordance with, the laws of the State of
Florida, including, without limitation, matters of construction, validity and performance. Each party to this Note
acknowledges that it has reviewed this Note and hereby agrees that the normal rule of construction to the effect that any
ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Note. In the
event any terms or provisions of this Note are held invalid or unenforceable, the remaining terms and conditions of this Note
shall continue to be fully enforceable without change, and this Note shall be interpreted as if the invalid or unenforceable
provision had not been a part hereof.


 


Creditor
and Debtor have executed this Note as of the date set forth above:







 





	CREDITOR	 	DEBTOR
	 	 	 	 	 
	HORNE MANAGEMENT, LLC	 	H-CYTE, INC.
	 	 	 	 	 
	BY:	/s/ William E. Horne                            	 	BY:	/s/ Jeremy Daniel
	 	William E. Horne, Manager	 	 	Jeremy Daniel, CFO
	 	 	 	 	 
	Date:	07/19/2019	 	Date:	07/25/2019
HUMBLE v. SARA LEE CORP.

No. COA04-131

Court of Appeals of North Carolina

Filed February 15, 2005

Certification Date March 7, 2005

Case reported without published opinion. Affirmed.
CHARLES T. SHERWIN, Employee, Plaintiff v. CAPE FEAR VALLEY HEALTH SYSTEM, Employer, SELF-INSURED, Defendant

No. COA04-513

North Carolina Court of Appeals.

Filed December 21, 2004.

This case not for publication

Industrial Commission I.C. No. 123003.

Charles T. Sherwin, pro se plaintiff-appellant.

Morris York Williams Surles & Barringer, LLP, by Stephen Kushner, for defendant-appellee.

STEELMAN, Judge.

Plaintiff appeals from an opinion and award of the North Carolina Industrial Commission ("the Commission") denying his claim for workers' compensation benefits. Although plaintiff also gave notice of appeal from the Commission's 14 October 2003 order denying his motion for reconsideration, his assignments of error and arguments on appeal do not separately address this order. Accordingly, we confine our review to the opinion and award filed 22 September 2003.

Plaintiff has submitted to this Court only six pages of the transcript of his hearing before the Deputy Commissioner. He has not included in the record on appeal any narrative of the testimonial evidence adduced at the hearing; nor has he provided this Court with any of the medical records or other documentary evidence placed before the Commission. *See* N.C. R. App. P. 9(c), (d), 18(c)(6)-(8). Further, plaintiff has violated multiple North Carolina Rules of Appellate Procedure, including Rule 9(a)(2)(b), Rule 10(c)(1), Rule 28(b)(1), Rule 28(b)(2), Rule 28(b)(3), Rule 28(b)(4), Rule 28(b)(5), Rule 28(b)(6), Rule 28(b)(7) and Rule 28(b)(8).

The Rules of Appellate Procedure are mandatory; failure to comply with these rules subjects an appeal to dismissal. *Steingress v. Steingress,*350 N.C. 64, 65, 511 S.E.2d 298, 299 (1999). Furthermore, these rules apply to everyone - whether acting *pro se* or being represented by all of the five largest law firms in the state. Because plaintiff violated many of the appellate rules, his appeal must be dismissed, notwithstanding his *pro se* status.

*Bledsoe v. County of Wilkes,*135 N.C. App. 124, 519 S.E.2d 316 (1999). Additionally, we have reviewed this case on its merits and conclude that plaintiff's arguments are without merit.

DISMISSED. Judges HUNTER and ELMORE concur.

Report per Rule 30(e).